Block Listing Six Monthly Return

Induction Healthcare Group PLC

29 July 2024

 

Induction Healthcare Group PLC

("Induction", the "Company", or the "Group")

Block Listing Six Monthly Return

Induction Healthcare (AIM: INHC), a leading digital health platform driving transformation of healthcare systems worldwide, makes the following six monthly update on its block listing pursuant to AIM Rule 29 and Schedule 6 of the AIM Rules for Companies:

Name of applicant:		Induction Healthcare Group PLC LEI: 213800RY96GCZQW5TP19
Name of scheme:		The Induction Healthcare NTA Share Option Plan
Period of return:		From:	28/01/2024	To:	27/07/2024
Number and class of securities originally admitted and the date of admission		3,500,000 ordinary shares on 26 July 2021
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):		nil
Less: Number of securities issued/allotted under scheme(s) during the period:		nil
Equals: Balance under scheme(s) not yet issued/allotted at end of period:		1,701,352
Contact:		Louise Torr, Company Secretary [e-mail]

ENQUIRIES

Induction Healthcare Group Christopher Samler, Chair Paul Tambeau, Chief Executive Officer	[phone] [phone]
Singer Capital Markets (Nominated Adviser and Broker)	[phone]
Philip Davies

About Induction - www.inductionhealthcare.com

Induction (AIM: INHC) Induction delivers a suite of software solutions through a single integrated platform that transforms care delivery. Our system-wide applications help healthcare providers and administrators to deliver care at any stage remotely as well as face-to-face - giving the communities they serve greater flexibility, control and ease of access. Purpose-built for integration with leading Electronic Medical Record (EMR) platforms, our products offer immediate stand-alone value that becomes even greater when integrated with pre-existing systems.

Used at scale by national and regional healthcare systems, as well non-health government services, our applications are relied upon by hundreds of thousands of clinicians and millions of patients across almost every hospital in the British Isles. 

 

END